Gene: Mbtps2 (membrane-bound transcription factor peptidase, site 2) Rattus norvegicus
Analyze
Symbol: Mbtps2
Name: membrane-bound transcription factor peptidase, site 2
Description: Predicted to have metalloendopeptidase activity; predicted to be involved in bone maturation, membrane protein intracellular domain proteolysis, and regulation of cellular biosynthetic process; predicted to localize to the cytoplasm; orthologous to human MBTPS2 (membrane bound transcription factor peptidase, site 2); PARTICIPATES IN sterol regulatory element-binding protein signaling pathway; Endoplasmic Reticulum-associated degradation pathway; INTERACTS WITH 3,3',5,5'-tetrabromobisphenol A; bisphenol A; gamma-hexachlorocyclohexane.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: LRRGT00063; membrane-bound transcription factor protease, site 2; membrane-bound transcription factor site-2 protease
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0X40,258,933 - 40,309,047 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0X40,569,195 - 40,619,334 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4X58,708,065 - 58,757,022 (+)NCBIRGSC3.4rn4RGSC3.4
CeleraX38,039,020 - 38,086,670 (+)NCBICelera
Cytogenetic MapXq21NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
Molecular Pathway Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Mbtps2
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1566171
Created: 2006-02-09
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.